PubMed Central, : RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2022 April; 13(2): e0008. ISSN: 2076-9172Published online 2022 April 26. doi: 10.5041/RMMJ.10467.

Table 1.

Clinical-demographic Comparison of the Treated (n=28,261) versus Non-treated (n=467) Groups.

Parameter	Treated Group (n=28,261)	Non-treated Group (n=467)	P Value
Mean follow-up in months (range)	55.70 (0–131)	35.23 (0–128)	<0.001

Mean age in years (range)
at diagnosis	50.1 (0–105)	57.7 (20–95)	<0.001
at death	68.8 (18.7–101.2)	71.2 (40.7–95.5)	0.06
at end of follow-up^*	54.1 (4.5–105)	56.7 (20–96)	0.001

Sex
Male	5,489	143	<0.001
Female	22,772	324

Cause of death
Thyroid cancer	110	16	<0.001
Other	1,119	113	<0.001

^*This group includes only those subjects living at the end of follow-up for the SEER study and therefore excludes those who died from any cause during follow-up.

RMMJ Rambam Maimonides Medical Journal Rambam Health Care Campus 2022 April; 13(2): e0008. ISSN: 2076-9172

Published online 2022 April 26. doi: 10.5041/RMMJ.10467